State Street’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $848K | Buy |
113,579
+85,829
| +309% | +$641K | ﹤0.01% | 3519 |
|
|
2025
Q1 | $271K | Buy |
27,750
+5,750
| +26% | +$56.2K | ﹤0.01% | 3753 |
|
|
2024
Q4 | $119K | Buy |
22,000
+6,700
| +44% | +$36.2K | ﹤0.01% | 3960 |
|
|
2024
Q3 | $96.2K | Hold |
15,300
| – | – | ﹤0.01% | 3985 |
|
|
2024
Q2 | $96.8K | Sell |
15,300
-114,079
| -88% | -$722K | ﹤0.01% | 4022 |
|
|
2024
Q1 | $1.06M | Buy |
129,379
+11,100
| +9% | +$91K | ﹤0.01% | 3457 |
|
|
2023
Q4 | $986K | Buy |
118,279
+10,157
| +9% | +$84.7K | ﹤0.01% | 3484 |
|
|
2023
Q3 | $1.39M | Buy |
108,122
+2,882
| +3% | +$37.1K | ﹤0.01% | 3445 |
|
|
2023
Q2 | $1.68M | Buy |
105,240
+91,840
| +685% | +$1.47M | ﹤0.01% | 3465 |
|
|
2023
Q1 | $176K | Buy |
13,400
+1,700
| +15% | +$22.3K | ﹤0.01% | 4123 |
|
|
2022
Q4 | $87.9K | Hold |
11,700
| – | – | ﹤0.01% | 4408 |
|
|
2022
Q3 | $83K | Hold |
11,700
| – | – | ﹤0.01% | 4528 |
|
|
2022
Q2 | $131K | Buy |
+11,700
| New | +$131K | ﹤0.01% | 4395 |
|